These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14999741)

  • 61. Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers.
    Harris JA; Stein SW; Myrdal PB
    AAPS PharmSciTech; 2006 Mar; 7(1):E138-E145. PubMed ID: 28290035
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Biocompatible and biodegradable copolymer stabilizers for hydrofluoroalkane dispersions: a colloidal probe microscopy investigation.
    Wu L; da Rocha SR
    Langmuir; 2007 Nov; 23(24):12104-10. PubMed ID: 17958454
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Determining degree of saturation after application of transiently supersaturated metered dose aerosols for topical delivery of corticosteroids.
    Jones SA; Reid ML; Brown MB
    J Pharm Sci; 2009 Feb; 98(2):543-54. PubMed ID: 18548616
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preparation of cyclosporine A nanoparticles by evaporative precipitation into aqueous solution.
    Chen X; Young TJ; Sarkari M; Williams RO; Johnston KP
    Int J Pharm; 2002 Aug; 242(1-2):3-14. PubMed ID: 12176220
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Asymmetric flow field flow fractionation for the characterization of globule size distribution in complex formulations: A cyclosporine ophthalmic emulsion case.
    Qu H; Wang J; Wu Y; Zheng J; Krishnaiah YSR; Absar M; Choi S; Ashraf M; Cruz CN; Xu X
    Int J Pharm; 2018 Mar; 538(1-2):215-222. PubMed ID: 29341918
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Manipulation of corticosteroid release from a transiently supersaturated topical metered dose aerosol using a residual miscible co-solvent.
    Reid ML; Brown MB; Jones SA
    Pharm Res; 2008 Nov; 25(11):2573-80. PubMed ID: 18668352
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The effect of surfactant and suspending agent concentration on the effective particle size of metered-dose inhalers.
    Fedina LT; Zelkó R; Fedina LI; Szabados ZS; Szántó M; Vakulya G
    J Pharm Pharmacol; 1997 Dec; 49(12):1175-7. PubMed ID: 9466338
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Advanced delivery of ciclosporin A: present state and perspective.
    Liu H; Wang Y; Li S
    Expert Opin Drug Deliv; 2007 Jul; 4(4):349-58. PubMed ID: 17683249
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stability of cyclosporine in an extemporaneously compounded paste.
    Ghnassia LT; Yau DF; Kaye KI; Duggin GG
    Am J Health Syst Pharm; 1995 Oct; 52(20):2204-7. PubMed ID: 8564591
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Oral inhalation of cannabidiol delivered from a metered dose inhaler to alleviate cytokine production induced by SARS-CoV-2 and pollutants.
    Srichana T; Chunhachaichana C; Suedee R; Sawatdee S; Changsan N
    J Drug Deliv Sci Technol; 2022 Oct; 76():103805. PubMed ID: 36159727
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Stability of an ophthalmic micellar formulation of cyclosporine A in unopened multidose eyedroppers and in simulated use conditions.
    Chennell P; Delaborde L; Wasiak M; Jouannet M; Feschet-Chassot E; Chiambaretta F; Sautou V
    Eur J Pharm Sci; 2017 Mar; 100():230-237. PubMed ID: 28131754
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions.
    Stein SW; Myrdal PB
    J Pharm Sci; 2004 Aug; 93(8):2158-75. PubMed ID: 15236462
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Accounting for the effects of moderately increased pressure on the energetics of melting and solubility in metered dose inhalers.
    Mogalian E; Sepassi K; Myrdal PB
    Drug Dev Ind Pharm; 2008 Sep; 34(9):930-5. PubMed ID: 18800253
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Potential Use of Cyclosporine Ultrafine Solution Pressurised Metered- Dose Inhaler in the Treatment of COVID-19 Patients.
    Ehtezazi T
    Recent Adv Drug Deliv Formul; 2022; 16(1):3-15. PubMed ID: 34809553
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Low Drug Loading Hampers the Clinical Translation of Peptide Drugs-Containing Metered-Dose Inhalers.
    Huang Z; Shu L; Huang Y; Wu C; Pan X
    Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455386
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Liquid medication dispensing and dose monitoring: the CycloTech Cyclosporine Oral Solution Dispenser.
    Rossi SJ; McEnroe DL; Tanner T; Levy RE; Pouletty P
    Transplant Proc; 1999 Jun; 31(4A):65S-66S. PubMed ID: 10372052
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach.
    Ghiglioni DG; Martino PA; Bruschi G; Vitali D; Osnaghi S; Corti MG; Beretta G
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32326044
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Splitting of a three-dimensional liquid plug at an airway bifurcation.
    Fujioka H; Romanò F; Muradoglu M; Grotberg JB
    Phys Fluids (1994); 2022 Aug; 34(8):081907. PubMed ID: 36033359
    [TBL] [Abstract][Full Text] [Related]  

  • 79. DLC1 SAM domain-binding peptides inhibit cancer cell growth and migration by inactivating RhoA.
    Joshi R; Qin L; Cao X; Zhong S; Voss C; Min W; Li SSC
    J Biol Chem; 2020 Jan; 295(2):645-656. PubMed ID: 31806702
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Advances in metered dose inhaler technology: formulation development.
    Myrdal PB; Sheth P; Stein SW
    AAPS PharmSciTech; 2014 Apr; 15(2):434-55. PubMed ID: 24452499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.